Apo2L/TRAIL is an indirect mediator of apoptosis induced by interferon-alpha in human myeloma cells (Q40358490)

19 September 2017

title

Apo2L/TRAIL is an indirect mediator of apoptosis induced by interferon-alpha in human myeloma cells (English)

1 reference

19 September 2017

Maria Gómez-Benito

1

1 reference

19 September 2017

Patricia Balsas

2

1 reference

19 September 2017

Alberto Bosque

3

1 reference

19 September 2017

Alberto Anel

4

1 reference

19 September 2017

Isabel Marzo

5

1 reference

19 September 2017

Javier Naval

6

1 reference

19 September 2017

language of work or name

English

0 references

publication date

17 October 2005

1 reference

19 September 2017

1 reference

19 September 2017

volume

579

1 reference

19 September 2017

issue

27

1 reference

19 September 2017

page(s)

6217-6222

1 reference

Interferon in the treatment of hairy-cell leukemia

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Viewpoint on the impact of interferon in the treatment of multiple myeloma: benefit for a small proportion of patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Human myeloma cell apoptosis induced by interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.10.007

10.1016/J.FEBSLET.2005.10.007

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference